Acceptance and completion of rifapentine-based TB preventive therapy (3HP) among people living with HIV (PLHIV) in Kampala, Uganda—patient and health worker perspectives

Abstract Background A 12-dose, once-weekly regimen of isoniazid and rifapentine (3HP) is effective in preventing tuberculosis (TB) among people living with HIV (PLHIV). We sought to identify potential barriers to and facilitators of acceptance and completion of 3HP treatment from the perspective of...

Descripción completa

Detalles Bibliográficos

Autores principales:	Fred C. Semitala, Allan Musinguzi, Jackie Ssemata, Fred Welishe, Juliet Nabunje, Jillian L. Kadota, Christopher A. Berger, Achilles Katamba, Noah Kiwanuka, Moses R. Kamya, David Dowdy, Adithya Cattamanchi, Anne R. Katahoire
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	BMC 2021-06-01
Colección:	Implementation Science Communications
Materias:	Tuberculosis Preventive therapy Perceived barriers Perceived facilitators People living with HIV Health workers
Acceso en línea:	https://doi.org/10.1186/s43058-021-00173-2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!